Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects

This study has been terminated.

(Few subjects recruited, sponsor withdrew support.)

Sponsor:

Collaborator:

Merck Frosst Canada Ltd.

Information provided by:

Sir Mortimer B. Davis - Jewish General Hospital

ClinicalTrials.gov Identifier:

NCT00388388

First received: October 13, 2006

Last updated: September 28, 2009

Last verified: September 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)